Advanced search
Publication Cover
HIV Clinical Trials Volume 11, 2010 - Issue 1
Submit an article Journal homepage
116
Views
47
CrossRef citations to date
0
Altmetric
Brief reports

Memantine for AIDS Dementia Complex: Open-Label Report of ACTG 301

Yu ZhaoHarvard School of Public Health Boston, Massachusetts, USACorrespondence[email protected]
,
Bradford A. NaviaTufts University School of Medicine Boston, Massachusetts, USA
,
Christina M. MarraUniversity of Washington, Seattle, Washington, USA
,
Elyse J. SingerUCLA Medical Center Los Angeles, California, USA
,
Linda ChangJohn A. Burns School of Medicine University of Hawaii, Honolulu, Hawaii, USA
,
Joseph BergerUniversity of Kentucky Medical Center, Lexington, Kentucky, USA
,
Ronald J. EllisUniversity of California at San Diego, San Diego, California, USA
,
Dennis L. KolsonUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA
,
David SimpsonMount Sinai School of Medicine, New York, New York, USA
,
Eric N. MillerUCLA Semel Institute for Neuroscience, Los Angeles, California, USA
,
Stuart A. LiptonSanford-Burnham Medical Research Institute and University of California, San Diego, La Jolla, California, USA
,
Scott R. EvansHarvard School of Public Health Boston, Massachusetts, USA
,
Giovanni SchifittoUniversity of Rochester, Rochester, New York, USA
& Adult AIDS Clinical Trial Group (ACTG) 301 Team show all
Pages 59-67 | Published online: 06 Jan 2015

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Heather M. Ma & Ross D. Zafonte. (2020) Amantadine and memantine: a comprehensive review for acquired brain injury. Brain Injury 34:3, pages 299-315.
Read now
Chengxiang Wu & Yuanan Lu. (2012) HIV treatment: mechanisms of neurotoxicity and implications for targeted therapy. Neurobehavioral HIV Medicine 4, pages 75-98.
Read now
Simon Rackstraw. (2011) HIV-related neurocognitive impairment – A review. Psychology, Health & Medicine 16:5, pages 548-563.
Read now

Articles from other publishers (44)

Wing Sze Tse, Bartłomiej Pochwat, Bernadeta Szewczyk, Paulina Misztak, Bartosz Bobula, Krzysztof Tokarski, Remigiusz Worch, Marta Czarnota-Bojarska, Stuart A. Lipton, Monika Zaręba-Kozioł, Monika Bijata & Jakub Wlodarczyk. (2023) Restorative effect of NitroSynapsin on synaptic plasticity in an animal model of depression. Neuropharmacology 241, pages 109729.
Crossref
Ronald J. Ellis, María J. Marquine, Marcus Kaul, Jerel Adam Fields & Johannes C. M. Schlachetzki. (2023) Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management. Nature Reviews Neurology 19:11, pages 668-687.
Crossref
George Minadakis, Marios Tomazou, Nikolas Dietis & George M Spyrou. (2023) Vir2Drug: a drug repurposing framework based on protein similarities between pathogens. Briefings in Bioinformatics 24:1.
Crossref
Tristan Russell, Disha Gangotia & Gerald Barry. (2022) Assessing the potential of repurposing ion channel inhibitors to treat emerging viral diseases and the role of this host factor in virus replication. Biomedicine & Pharmacotherapy 156, pages 113850.
Crossref
Dennis L. Kolson. (2022) Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND). Current HIV/AIDS Reports 19:5, pages 344-357.
Crossref
Congwu Du, Yueming Hua, Kevin Clare, Kicheon Park, Craig P. Allen, Nora D. Volkow, Xiu-Ti Hu & Yingtian Pan. (2022) Memantine Attenuates Cocaine and neuroHIV Neurotoxicity in the Medial Prefrontal Cortex. Frontiers in Pharmacology 13.
Crossref
Amila Omeragic, Olanre Kayode, Md Tozammel Hoque & Reina Bendayan. (2020) Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders. Fluids and Barriers of the CNS 17:1.
Crossref
Alan Winston & Serena Spudich. (2020) Cognitive disorders in people living with HIV. The Lancet HIV 7:7, pages e504-e513.
Crossref
Shih-Ping Lin, Andrea Calcagno, Scott L. Letendre & Qing Ma. 2021. Neurocognitive Complications of HIV-Infection. Neurocognitive Complications of HIV-Infection 517 545 .
Rupert McShane, Maggie J Westby, Emmert Roberts, Neda Minakaran, Lon Schneider, Lucy E Farrimond, Nicola Maayan, Jennifer Ware & Jean Debarros. (2019) Memantine for dementia. Cochrane Database of Systematic Reviews.
Crossref
Stephanie A. Cross & Dennis L. Kolson. 2018. Encyclopedia of AIDS. Encyclopedia of AIDS 1488 1494 .
Vir B. Singh, Meera V. Singh, Dorota Piekna-Przybylska, Santhi Gorantla, Larisa Y. Poluektova & Sanjay B. Maggirwar. (2017) Sonic Hedgehog mimetic prevents leukocyte infiltration into the CNS during acute HIV infection. Scientific Reports 7:1.
Crossref
Jacqueline Ellero, Michal Lubomski & Bruce Brew. (2017) Interventions for Neurocognitive Dysfunction. Current HIV/AIDS Reports 14:1, pages 8-16.
Crossref
Howard Fox & Phillip Purnell. 2017. Neuroimmune Pharmacology. Neuroimmune Pharmacology 407 420 .
L Chang, GC Løhaugen, V Douet, EN Miller, J Skranes & T Ernst. (2016) Neural correlates of working memory training in HIV patients: study protocol for a randomized controlled trial. Trials 17:1.
Crossref
Vir B. Singh, Meera V. Singh, Santhi Gorantla, Larisa Y. Poluektova & Sanjay B. Maggirwar. (2016) Smoothened Agonist Reduces Human Immunodeficiency Virus Type-1-Induced Blood-Brain Barrier Breakdown in Humanized Mice. Scientific Reports 6:1.
Crossref
Stephanie A. Cross & Dennis L. Kolson. 2014. Encyclopedia of AIDS. Encyclopedia of AIDS 1 7 .
Vez Repunte-Canonigo, Celine Lefebvre, Olivier George, Tomoya Kawamura, Marisela Morales, George F Koob, Andrea Califano, Eliezer Masliah & Pietro Paolo Sanna. (2014) Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Molecular Neurodegeneration 9:1.
Crossref
Jennifer L. McGuire, Jeffrey S. Barrett, Heather E. Vezina, Sergei Spitsin & Steven D. Douglas. (2014) Adjuvant therapies for HIV ‐associated neurocognitive disorders . Annals of Clinical and Translational Neurology 1:11, pages 938-952.
Crossref
Michael J. Peluso & Serena Spudich. (2014) Treatment of HIV in the CNS: Effects of Antiretroviral Therapy and the Promise of Non-Antiretroviral Therapeutics. Current HIV/AIDS Reports 11:3, pages 353-362.
Crossref
Fabián J. Vázquez-Santiago, Richard J. NoelJr.Jr., James T. Porter & Vanessa Rivera-Amill. (2014) Glutamate metabolism and HIV-associated neurocognitive disorders. Journal of NeuroVirology 20:4, pages 315-331.
Crossref
Maria Ferrara, Ignacio P. Valero, David J. Moore, Adam F. Knight, Nichole A. Duarte & J. Hampton Atkinson. 2014. HIV and Psychiatry. HIV and Psychiatry 157 210 .
Daniel F. Marker, Shao-Ming Lu & Harris A. Gelbard. 2014. Microglia in Health and Disease. Microglia in Health and Disease 373 392 .
Sandra M. Vetiska & Michael Tymianski. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity 1381 1402 .
Belinda Cruse & Bruce J. Brew. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity 1247 1265 .
Nicholas J. Hargus & Stanley A. Thayer. (2013) Human Immunodeficiency Virus-1 Tat Protein Increases the Number of Inhibitory Synapses between Hippocampal Neurons in Culture. The Journal of Neuroscience 33:45, pages 17908-17920.
Crossref
David B Clifford & Beau M Ances. (2013) HIV-associated neurocognitive disorder. The Lancet Infectious Diseases 13:11, pages 976-986.
Crossref
Jonathan S. Stamler. (2013) Redox Pioneer: Professor Stuart A. Lipton. Antioxidants & Redox Signaling 19:8, pages 757-764.
Crossref
Linda Nabha, Lan Duong & Joseph Timpone. (2013) HIV-Associated Neurocognitive Disorders: Perspective on Management Strategies. Drugs 73:9, pages 893-905.
Crossref
Michelle C. Potter, Mariana Figuera-Losada, Camilo Rojas & Barbara S. Slusher. (2013) Targeting the Glutamatergic System for the Treatment of HIV-Associated Neurocognitive Disorders. Journal of Neuroimmune Pharmacology 8:3, pages 594-607.
Crossref
Lukas Wanka, Khalid Iqbal & Peter R. Schreiner. (2013) The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives. Chemical Reviews 113:5, pages 3516-3604.
Crossref
Renan Domingues. 2013. Neuroviral Infections. Neuroviral Infections 129 142 .
Samanta Simioni, Matthias Cavassini, Jean-Marie Annoni, Mélanie Métral, Katia Iglesias, Aline Rimbault Abraham, Samantha Jilek, Alexandra Calmy, Hubertus Müller, Aurélie Fayet-Mello, Ezio Giacobini, Bernard Hirschel & Renaud A. Du Pasquier. (2013) Rivastigmine for HIV-associated neurocognitive disorders. Neurology 80:6, pages 553-560.
Crossref
Justin McArthur & Bryan Smith. (2013) Neurologic Complications and Considerations in HIV-Infected Persons. Current Infectious Disease Reports 15:1, pages 61-66.
Crossref
JoEllyn McMillan & Howard E. Gendelman. 2013. Neural-Immune Interactions in Brain Function and Alcohol Related Disorders. Neural-Immune Interactions in Brain Function and Alcohol Related Disorders 211 248 .
Ik L. Tan & Justin C. McArthur. (2012) HIV-Associated Neurological Disorders. CNS Drugs 26:2, pages 123-134.
Crossref
David Scemes & Eliana SprayDaniela Rossi & Andrea Volterra. 2011. Astrocytes. Astrocytes 157 178 .
Daniela Rossi, Francesca Martorana & Liliana Brambilla. (2011) Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders. CNS Drugs 25:8, pages 641-658.
Crossref
. (2011) Current World Literature. Current Opinion in Neurology 24:3, pages 300-307.
Crossref
E.C. Rosca, O. Rosca, R.D. Chirileanu & M. Simu. (2011) Neurocognitive disorders due to HIV infection. HIV & AIDS Review 10:2, pages 33-37.
Crossref
Judith Schouten, Paola Cinque, Magnus Gisslen, Peter Reiss & Peter Portegies. (2011) HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 25:5, pages 561-575.
Crossref
Victor Valcour, Pasiri Sithinamsuwan, Scott Letendre & Beau Ances. (2010) Pathogenesis of HIV in the Central Nervous System. Current HIV/AIDS Reports 8:1, pages 54-61.
Crossref
Samanta Simioni, Matthias Cavassini, Jean-Marie Annoni, Bernard Hirschel & Renaud A Du Pasquier. (2011) HIV-associated neurocognitive disorders: a changing pattern. Future Neurology 6:1, pages 81-95.
Crossref
Sunita Gupta, Alecia G. Knight, Shruti Gupta, Pamela E. Knapp, Kurt F. Hauser, Jeffrey N. Keller & Annadora J. Bruce-Keller. (2010) HIV-Tat elicits microglial glutamate release: Role of NAPDH oxidase and the cystine–glutamate antiporter. Neuroscience Letters 485:3, pages 233-236.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.